An open‐label, multi‐centre, post‐marketing study to assess the efficacy and safety of a plasma‐derived VWF/FVIII concentrate in patients with von Willebrand disease. - Miesbach, Wolfgang; Halimeh, Susan; Platokouki, Helen; Podolak‐Dawidziak, Maria; Zdziarska, Joanna; Korczowski, Bartosz; Chowdary, Pratima; Austin, Steve; Millar, Carolyn; Alamelu, Jayanthi; Rogosch, Tobias; Pabinger, Ingrid (Haemophilia, 2024)